CRUK SACT regimen-specific consent form project
The CRUK SACT regimen-specific consent form project team is pleased to announce that a number of consent forms have been developed and published. They are now available on the CRUK website at: www.cruk.org/sact_consent.
- Children and Young Persons Acute Lymphoblastic Leukaemia / Lymphoma
- Kaposi Sarcoma
- Consent forms for docetaxel and liposomal daunorubicin (DaunoXome) have been archived
- CML
- A consent form for asciminib has been added
- GIST
- AML
- Azacitidine oral option added to consent form
- Vinorelbine Update
- Timelines for contraception amended in vinorelbine-containing consent forms in accordance with updated manufacturers guidance
- Affected forms: vinorelbine oral (breast), vinorelbine oral, vinorelbine IV, vinorelbine-cisplatin, vinorelbine-carboplatin (lung). Vinorelbine IV and vinorelbine-capecitabine (breast) will be updated as part of group revalidation currently underway
- Generic Updates
- Fertility and pregnancy statements have been updated to utilise inclusive and gender neutral language
- Risk of viral infection worsening or re-activation in line with the UK SACT Board position statement (2022)
Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.
Best Wishes,
Lucy
Lucy Cox
Cancer Research UK Specialist Pharmacist – Cancer Information Lead
Guy’s and St Thomas’ NHS Foundation Trust
Guy’s Hospital, Great Maze Pond, London, SE1 9RT
